Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,102.44 -712.12 (-1.83%) Hang Seng
17,936.12 -5.66 (-0.03%) FTSE 100
8,161.40 +14.54 (+0.18%) Bitcoin USD
66,066.90 -209.77 (-0.32%) CMC Crypto 200
1,387.71 -0.45 (-0.03%)
PCRX Dec 2024 25.000 call
| Previous close | 8.25 |
| Open | 7.60 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 25.00 |
| Expiry date | 2024-12-20 |
| Day's range | 7.60 - 8.25 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
GuruFocus.comInsider Sale: Chief Medical Officer Jonathan Slonin Sells Shares of Pacira BioSciences Inc (PCRX)
Jonathan Slonin, Chief Medical Officer of Pacira BioSciences Inc (NASDAQ:PCRX), executed a sale of 5,012 shares of the company on June 11, 2024, as reported in a recent SEC Filing.
GlobeNewswirePacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
TAMPA, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2024 Jefferies Global Healthcare Conference at 11:00 AM ET on Thursday, June 6, 2024 in New York. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event. About Pacira Pacira BioSciences, In
Simply Wall St.Earnings Miss: Pacira BioSciences, Inc. Missed EPS By 17% And Analysts Are Revising Their Forecasts
Investors in Pacira BioSciences, Inc. ( NASDAQ:PCRX ) had a good week, as its shares rose 9.3% to close at US$29.86...
